The role of metabolism in determining susceptibility to parathion toxicity in man

Toxicology Letters

Volumn 107, Issue 1-3, 1999, Pages 177-187

  Mutch, Elaine ^a   Blain, Peter G ^a   Williams, Faith M ^a  

^a NONE

Author keywords

Acetylcholinesterase; Acute toxicity; CYP3A; Interindividual variations; Parathion; Phosphorothioate pesticides

Indexed keywords

4 NITROPHENOL; ALPHA NAPHTHOFLAVONE; ARYLDIALKYLPHOSPHATASE; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 ISOENZYME; DIETHYLDITHIOCARBAMIC ACID; EDETIC ACID; ESTERASE; ETHOXYRESORUFIN DEETHYLASE; KETOCONAZOLE; METYRAPONE; NARINGENIN; NIFEDIPINE; OXYGENASE; PARAOXON; PARATHION; PENTOXYRESORUFIN DEALKYLASE; PESTICIDE; QUERCETIN; QUINIDINE; SULFAPHENAZOLE; TOLBUTAMIDE; TROLEANDOMYCIN;

BIOTRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DEALKYLATION; DETOXIFICATION; DRUG OXIDATION; ENZYME KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; INDIVIDUALITY; LIVER MICROSOME METABOLISM; METABOLIC ACTIVATION; PRIORITY JOURNAL;

CYTOCHROME P-450 ENZYME SYSTEM; EDETIC ACID; HUMANS; INSECTICIDES; MICROSOMES, LIVER; NIFEDIPINE; PARATHION;

EID: 0033067399     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00044-2     Document Type: Conference Paper

References (37)

1. Aldridge W.N. A-esterases and B-esterases in perspective. Reiner E., Aldrich W.N., Hoskin F.C.G. Enzymes Hydrolysing Organophosphorus Compounds. 1989;1-14 Ellis Horwood Publications, Chichester.
2. Aoyama T., Yamano S., Waxman D.J. Cytochrome P450 hPCN3, a novel cytochrome P450 gene product that is differently expressed in adult human liver. J. Biol. Chem. 264:1989;10388-10395.
3. Burke M.D., Mayer R.T. Ethoxyresorufin in direct fluorimetric assay of a microsomal O-deethylation which is preferentially inducible by 3-methylcholanthrene. Drug. Metab. Dispos. 2:1974;583-588.
4. Butler A.M., Murray M. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. J. Pharmacol. Exp. Ther. 280:1997;966-973.
5. Chambers J.E., Ma T., Boone J.S., Chambers H.W. Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticide in the rat. Life. Sci. 54:1994;1357-1364.
6. Chang T.K.H., Gonzalez F.J., Waxman D.J. Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys. 311:1994;437-442.
7. Eckerson H.W., Wyte C., La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35:1983;1126-1138.
8. Fleming C.M., Branch R.A., Wilkinson G.R., Guengerich F.P. Human liver microsomal N-hydroxylation of dapsone by cytochrome P450 3A4. Mol. Pharmacol. 41:1992;975-980.
9. Gallo M.A., Lawryk N.J. Organic phosphorus pesticides. Hayes W.J., Laws E.R. Handbook of Pesticide Toxicology. 2:1991;917-1123 Academic Press, San Diego.
10. Gil F., Pla A., Gonzalvo M.C., Hernandez A.F., Villanueva E. Rat liver paraoxonase: subcellular distribution and characterization. Chem. Biol. Interact. 87:1993;149-154.
11. Gonzales F.J. Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci. 13:1992;346-352.
12. Guengerich F.P., Kim D.H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B-1 activation in human liver microsomes by naringenin and other flavanoids. Carcinogenesis. 11:1990;2275-2279.
13. Guengerich F.P., Turvy C.G. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256:1990;1189-1194.
14. Guengerich F.P., Muller-Enoch D., Blair I.A. Oxidation of quinidine by human liver cytochrome P450. Mol. Pharmacol. 30:1986;287-295.
15. Guengerich F.P. Mechanism-based inactivation of human liver microsomal cytochrome P450 111A4 by gestodene. Chem. Res. Toxicol. 3:1990;363-371.
16. Iribarne C., Berthou F., Bairde S., Dreano Y., Picart D., Bail J.P., Beaune P., Menez J.F. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem. Res. Toxicol. 9:1996;365-373.
17. Joanovïc M., Kosanovïc M., Maksimovïc M. Interaction of organophosphorus compounds with carboxylesterases in the rat. Arch. Toxicol. 70:1996;444-450.
18. Kamataki T., Leelin M.C.M., Belcher D.H., Neal R.A. Studies of the metabolism of parathion with an apparently homogenous preparation of rabbit liver microsomal cytochrome P450. Drug. Metab. Dispos. 4:1976;180-189.
19. Koley A.P., Buters J.T.M., Robinson R.C., Friedman F.K. CO binding kinetics of human cytochrome P450 3A4. J. Biol. Chem. 270:1995;5014-5018.
20. Kumar G.N., Walle U.K., Walle T. Cytochrome P450 3A-mediated human liver microsomal taxol 6α-hydroxylation. J. Pharm. Exp. Ther. 268:1993;1160-1165.
21. Ma T., Chambers J.E. A kinetic analysis of hepatic microsomal activation of parathion and chlorpyrifos in control and phenobarbital-treated rats. J. Biochem. Toxicol. 10:1995;63-68.
22. Mackness M.I. A-esterases. Enzymes looking for a role? Biochem. Pharmacol. 38:1989;385-390.
23. Maurice M., Pichard L., Daujat M., Fabre I., Joyeux H., Domergue J., Maurel P. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB. J. 6:1992;752-758.
24. Mutch E., Blain P.G., Kelly S.S., Williams F.M. Comparative studies of two organophosphorus compounds in the mouse. Tox. Letts. 81:1995;45-53.
25. Mutch E., Blain P.G., Williams F.M. Cytochrome P450 isozymes involved in parathion metabolism in the rat. Hum. Exp. Toxicol. 15:1996;689.
26. Mutch, E., 1998. The role of metabolism in determining susceptibility to parathion toxicity. PhD thesis, University of Newcastle-upon-Tyne, UK.
27. Nakatsugawa T., Tolman N.M., Dahm P.A. Degradation and activation of parathion analogs by microsomal enzymes. Biochem. Pharmacol. 17:1968;1517-1528.
28. Norman B.J., Poore R.E., Neal R.A. Studies of the binding of sulfur released in the mixed-function oxidase-catalysed metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) to diethyl p-nitrophenyl phosphate (paraoxon). Biochem. Pharmacol. 23:1974;1733-1744.
29. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356.
30. Schmid B.J., Perry H.E., Idle J.R. Determination of nifedipine and its three principal metabolites in plasma and urine by automated electron-capture capillary gas chromatography. J. Chromatog. 425:1988;107-119.
31. Shimada T., Guengerich F.P. Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazole [4,5-b] pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P450 enzymes in rat and human liver microsomes. Cancer Res. 51:1991;5284-5291.
32. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich P.F. Interindividual variations in human liver P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:1994;414-423.
33. Tassaneeyakul W., Birkett D.J., Veronese M.E., McManus M.E. et al. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 265:1993;401-407.
34. Verschoyle R.D., Dinsdale D., Wolf C.R. Inhibition and induction of cytochrome P450 isoenzymes in rat lung. J. Pharmacol. Exp. Ther. 265:1993;386-391.
35. Waziers I., Cugnenc P.H., Yang C.S., Leroux J.P., Beaune P.H. Cytochrome P450 isozymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissue. J. Pharmacol. Exp. Ther. 253:1990;387-394.
36. Yamazaki H., Inui Y., Yun C.-H., Guengerich F.P., Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis. 13:1992;1789-1794.
37. Zerilli A., Ratanasavanh D., Lucas D., Goadstuff T. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem. Res. Toxicol. 10:1997;1205-1212.